|
Daratumumab/rHuPH20 Co-formulation Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Daratumumab and Hyaluronidase-fihj, Darzalex FASPRO
Detroit, Michigan1 trial
Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Karmanos Cancer Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.